Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A | P11388 | 1/20 | 0.43 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.41 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.41 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.37 |
| ▸ | TYR | P14679 | 1/20 | 0.37 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.37 |
| ▸ | CDK2 | P24941 | 1/20 | 0.37 |
| ▸ | GSK3A | P49840 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12838754 | 0.94 | CYP1A2 (0.43) | CYP1A2CYP2C19CYP3A4GAAMAPT | |
| SCHEMBL12839737 | 0.92 | FGFR1 (0.43) | FGFR1FGFR2FGFR3CYP1A2CYP2C19 | |
| SCHEMBL12839433 | 0.89 | TYR (0.42) | FGFR1FGFR2FGFR3CYP1A2CYP2C19 | |
| SCHEMBL12840192 | 0.88 | DHODH (0.43) | FGFR1FGFR2FGFR3CYP1A2CYP2C19 | |
| SCHEMBL12839100 | 0.87 | CYP1A2 (0.50) | FGFR1FGFR2FGFR3CYP1A2CYP2C19 | |
| SCHEMBL12840675 | 0.87 | TOP2A (0.41) | TOP2ATYRCDK2GSK3AGSK3B | |
| SCHEMBL12840640 | 0.87 | TOP2A (0.41) | TOP2AGAAMAPTCYP2C9DEGS1 | |
| SCHEMBL12840247 | 0.85 | MAPT (0.52) | CYP1A2CYP2C19CYP3A4MAPTCYP2C9 | |
| SCHEMBL12840708 | 0.85 | HCAR2 (0.42) | TOP2ACYP2C9LMNA | |
| SCHEMBL13068338 | 0.85 | CDK2 (0.41) | TOP2AGAACYP2C9DEGS1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110070656-A1 | Fluorescent Proteins | JNC CORPORATION (JP) | 2011-03-24 | — | — | US | disclosed |
| EP-1666488-B1 | FLUORESCENT PROTEIN | CHISSO CORP (JP) | 2010-11-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110070656-A1 | Fluorescent Proteins | CACYBP, CHLSN, LCP2 | TOP2A 3075/4885FGFR1 3660/4885FGFR2 4317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.